Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 4/20 | 0.78 |
| ▸ | ABCC4 | O15439 | 3/20 | 0.78 |
| ▸ | ABCC2 | Q92887 | 3/20 | 0.78 |
| ▸ | GAA | P10253 | 3/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.78 |
| ▸ | ABCC3 | O15438 | 2/20 | 0.78 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.78 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.78 |
| ▸ | SLCO1A2 | P46721 | 2/20 | 0.78 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.78 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.78 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30478467 | 0.96 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL29477247 | 0.94 | ABCB11 (0.77) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL29477244 | 0.94 | ABCB11 (0.77) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL29625757 | 0.94 | MAPT (0.80) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL30248308 | 0.94 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL30478471 | 0.94 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL30248384 | 0.94 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL30478462 | 0.94 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL29477254 | 0.94 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA | |
| SCHEMBL29477253 | 0.94 | ABCB11 (0.76) | MAPTABCB11ABCC4ABCC2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115176024-A | Astaxanthin high-producing strain of phaffia rhodozyma | 纳斯特姆科技有限公司 | 2022-10-11 | — | — | CN | claimed |
| US-20220290119-A1 | Astaxanthin Over-Producing Strains of Phaffia Rhodozyma | NEXTFERM TECHNOLOGIES LTD. (IL) | 2022-09-15 | — | — | US | claimed |
| EP-4004225-A1 | ASTAXANTHIN OVER-PRODUCING STRAINS OF PHAFFIA RHODOZYMA | NextFerm Technologies Ltd. (IL) | 2022-06-01 | — | — | EP | claimed |
| US-12139446-B2 | Arylamine compound, hole-transport layer material, hole-injection layer material, light-emitting device, light-emitting apparatus, electronic apparatus, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-11-12 | — | — | US | disclosed |
| US-20240277828-A1 | MULTIVALENT INFLUENZA VACCINES COMPRISING RECOMBINANT HEMAGGLUTININ AND NEURAMINIDASE AND METHODS OF USING THE SAME | SANOFI PASTEUR INC. | 2024-08-22 | — | — | US | disclosed |
| CN-118201635-A | Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of use thereof | 圣诺菲·帕斯图尔公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-4316503-A1 | PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023081798-A1 | MULTIVALENT INFLUENZA VACCINES COMPRISING RECOMBINANT HEMAGGLUTININ AND NEURAMINIDASE AND METHODS OF USING THE SAME | SANOFI PASTEUR INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| CN-115176024-A | Astaxanthin high-producing strain of phaffia rhodozyma | 纳斯特姆科技有限公司 | 2022-10-11 | — | — | CN | disclosed |
| US-20220290119-A1 | Astaxanthin Over-Producing Strains of Phaffia Rhodozyma | NEXTFERM TECHNOLOGIES LTD. (IL) | 2022-09-15 | — | — | US | disclosed |
| EP-4004225-A1 | ASTAXANTHIN OVER-PRODUCING STRAINS OF PHAFFIA RHODOZYMA | NextFerm Technologies Ltd. (IL) | 2022-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220290119-A1 | Astaxanthin Over-Producing Strains of Phaffia Rhodozyma | RPIA, FDFT1, CYP51A1 | MAPT 4438/4885ABCB11 2255/4885ABCC4 1299/4885 |
| US-12139446-B2 | Arylamine compound, hole-transport layer material, hole-injection layer material, light-emitting device, light-emitting apparatus, electronic apparatus, and lighting device | AHR, ARNT, AAAS | MAPT 2881/4885ABCB11 12/4885ABCC4 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.